AllSight
Companies · PRAX · Pharmaceutical Preparations

Praxis Precision Medicines, Inc. (PRAX)

Praxis Precision Medicines, Inc. (PRAX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Praxis Precision Medicines, Inc. (PRAX) stock — financials & valuation

Key numbers for Praxis Precision Medicines, Inc. (PRAX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 38/100 — a percentile rank of Praxis Precision Medicines, Inc.’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.

Market cap$8.0B
EV / EBITDA-19.9×
Return on equity-25.3%
ROIC-43.7%
Revenue growth-100.0%
Debt / equity0.0×
Dividend yield0.0%

Is Praxis Precision Medicines, Inc. overvalued? P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from Praxis Precision Medicines, Inc.’s own financial statements and shown as context, never as advice.

Aug 6, 2026
Quarterly results were furnished, but the actual results are not included here
Related companies in Pharmaceutical Preparations
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact